Skip to content

Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ)

Reliability and Validity Study of the Facilitators and Barriers Exercise Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03125590
Enrollment
114
Registered
2017-04-24
Start date
2017-04-01
Completion date
2017-08-11
Last updated
2017-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopenia, Osteoporosis, Postmenopausal

Keywords

Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity

Brief summary

The PEQ is the first tool to measure facilitators, barriers, and preferences to exercise in people with osteoporosis.

Detailed description

Osteoporosis is a disease of the bones characterized by low bone mass and microarchitectural deterioration of bone tissue. This disease can increase the risk of bone fragility fractures and is indirectly associated with premature death. These fractures are more common than cancer or heart disease in North American women 50 years or older, with an osteoporotic fracture occurring every 3 seconds worldwide, and are a major issue to patients and the healthcare system. Increased fracture rates, particularly in the hip and spine, may lead to hospitalization and subsequent immobility. Some studies have shown fitness to be a better predictor of bone mineral density than age, yet adherence to exercise is poor. Studies suggest that 50% of those registered in an exercise program drop out within the first 6 months, lack of time being the number one barrier in many populations. To increase adherence to an exercise program, a systematic review has identified a number of facilitators and barriers to exercise in adults with osteoporosis and osteopenia. Hitherto, no measurement tool has been created to measure these facilitators and barriers in people with osteoporosis. The investigators have developed and validated the PEQ (Personalized Exercise Questionnaire), a new tool that can measure the facilitators, barriers, and preferences to exercise. The next steps are to test the reliability, known-group validity, and pilot test this tool in the osteoporosis population. Future physical activity or exercise interventions could benefit from using this tool to leveraging the facilitators and limiting the barriers to exercise to increase adherence to an exercise program.

Interventions

OTHERTesting the PEQ (Personalized Exercise Questionnaire)

Administer the questionnaire to 114 participants to classify their facilitators, barriers and preferences to exercise

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. The participant is able and willing to provide informed consent 2. The participant is male or female, 18+ 3. The participant has received a diagnosis, from a physician, of primary osteopenia or osteoporosis (T \< - 1.0) 4. The participant can read and write English

Exclusion criteria

1. The participant has been diagnosed with secondary osteopenia or osteoporosis 2. The participant has a history of smoking, alcoholism, gastrointestinal disease, hypercalciuria and/or steroid use. 3. The participant is diagnosed with a reading disability or dyslexia 4. The participant has a cognitive impairment of some severity as to adversely affect the validity of the data

Design outcomes

Primary

MeasureTime frameDescription
Reliability of the PEQ3 monthsThis study requires 114 participants for pilot testing of the questionnaire. A subset of 46 patients will be used for the reliability study to determine the test-retest. The questionnaire will be administered at baseline and subsequently completed again after approximately 1 week. Test-retest will determine the reproducibility of this questionnaire. Intraclass correlation (ICC) model 2, form 2 (ICC 2, 2) will be used. Internal consistency is expressed by Cronbach's alpha, which is a measure of the reliability of the summative rating scale will also be used.
Known Group-Validity3 monthsKnown Group Validity is a type of validity that measures the extent to which a questionnaire is sensitive to the differences and similarities between two groups. For example, the investigators may hypothesize that participants from lower socio-economic status (SES) would have cost as a barrier to exercise compared to participants from a higher SES. Hypothesizes will be identified from the literature and tested to determine known group validity. Differences between hypothesized groups will be assessed using an ANOVA and Chi-Square test.

Secondary

MeasureTime frameDescription
Preferences to exercise3 monthsUsing the PEQ, domains two and four, will be used to quantify the frequency of each preference. Results will be presented in a table with column one representing the survey item and column two representing the frequency of the reported outcome.
Barriers to exercise3 monthsUsing the PEQ, domain six, will be used to quantify the frequency of each barrier. Results will be presented in a table with column one representing the survey item and column two representing the frequency of the reported outcome.
Exercise Goals3 monthsUsing the PEQ, domain three, will be used to quantify the frequency of each goal. Results will be presented in a table with column one representing the survey item and column two representing the frequency of the reported outcome.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026